The Renin/angiotensin System

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1981 Nov 1

PMID 6174135

Citations 1

Authors

M R Lee

Affiliations

Soon will be listed here.

Citing Articles

Pharmacokinetics and plasma-concentration-effect relationships of prenalterol in cardiac failure.

Sainsbury E, Fitzpatrick D, Ikram H, Nicholls M, Espiner E, ASHLEY J Eur J Clin Pharmacol. 1985; 28(4):397-403.

PMID: 2863151 DOI: 10.1007/BF00544357.

References

Brown J, Davies D, Lever A, Robertson J, Tree M . The estimation of renin in human plasma. Biochem J. 1964; 93(3):594-600. PMC: 1214014. DOI: 10.1042/bj0930594. View

Skinner S . Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate. Circ Res. 1967; 20(4):391-402. DOI: 10.1161/01.res.20.4.391. View

MICHELAKIS A, Woods J, LIDDLE G, KLATTE E . A predictable error in use of renal vein renin in diagnosing hypertension. Arch Intern Med. 1969; 123(4):359-61. View

Piquilloud Y, REINHARZ A, Roth M . Studies on the angiotensin converting enzyme with different substrates. Biochim Biophys Acta. 1970; 206(1):136-42. DOI: 10.1016/0005-2744(70)90090-2. View

Boyd G, Adamson A, Arnold M, James V, Peart W . The role of angiotensin II in the control of aldosterone in man. Clin Sci. 1972; 42(1):91-104. DOI: 10.1042/cs0420091. View

Stockigt J, Collins R, Noakes C, Schambelan M, Biglieri E . Renal-vein renin in various forms of renal hypertension. Lancet. 1972; 1(7762):1194-7. DOI: 10.1016/s0140-6736(72)90922-1. View

ENGEL S, Schaeffer T, Gold B, Rubin B . Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides. Proc Soc Exp Biol Med. 1972; 140(1):240-4. DOI: 10.3181/00379727-140-36433. View

Cheung H, Cushman D . Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca. Biochim Biophys Acta. 1973; 293(2):451-63. DOI: 10.1016/0005-2744(73)90352-5. View

Brunner H, Gavras H, LARAGH J . Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet. 1973; 2(7837):1045-8. DOI: 10.1016/s0140-6736(73)92657-3. View

10.

Gant N, Chand S, WHALLEY P, MACDONALD P . The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol. 1974; 43(6):854. View

11.

Lowder S, LIDDLE G . Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension. N Engl J Med. 1974; 291(23):1243-4. DOI: 10.1056/NEJM197412052912309. View

12.

Lowder S, LIDDLE G . Effects of guanethidine and methyldopa on a standardized test for renin responsiveness. Ann Intern Med. 1975; 82(6):757-60. DOI: 10.7326/0003-4819-82-6-757. View

13.

Lieberman J . Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975; 59(3):365-72. DOI: 10.1016/0002-9343(75)90395-2. View

14.

Davis J, Freeman R . Mechanisms regulating renin release. Physiol Rev. 1976; 56(1):1-56. DOI: 10.1152/physrev.1976.56.1.1. View

15.

Douglas J, Catt K . Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes. J Clin Invest. 1976; 58(4):834-43. PMC: 333246. DOI: 10.1172/JCI108536. View

16.

Samuels A, Miller Jr E, Fray J, Haber E, BARGER A . Renin--angiotensin antagonists and the regulation of blood pressure. Fed Proc. 1976; 35(13):2512-20. View

17.

Kotchen T, Talwalker R, Miller M, Welch W . Modification of renin reactivity by lipids extracted from normal, hypertensive, and uremic plasma. J Clin Endocrinol Metab. 1976; 43(5):971-81. DOI: 10.1210/jcem-43-5-971. View

18.

Case D, Wallace J, Keim H, SEALEY J, LARAGH J . Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med. 1976; 60(6):825-36. DOI: 10.1016/0002-9343(76)90903-7. View

19.

Thomas R, Ball S, Lee M . Failure of saralasin to predict a response to surgery in renovascular hypertension. Lancet. 1977; 1(8014):724-6. DOI: 10.1016/s0140-6736(77)92168-7. View

20.

ONDETTI M, Rubin B, Cushman D . Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science. 1977; 196(4288):441-4. DOI: 10.1126/science.191908. View